CoMentis

Industry · 9 registered clinical trials.

Status	Trial	Phase	Started
Suspended	Safety, Tolerability, and Pharmacokinetics of APN1125 in Subjects With Schizophrenia Schizophrenia	Phase 1 / Phase 2	2016-04-01
Completed	Safety, Tolerability, and Pharmacokinetics of Single Doses of APN1125 in Healthy Normal Subjects Schizophrenia	Phase 1	2014-12-01
Completed	Safety and Efficacy of ATG003 in Patients With AMD Receiving Anti-VEGF Age-Related Macular Degeneration	Phase 2	2008-05-01
Completed	Topical Ocular Mecamylamine in Diabetic Macular Edema (DME) Diabetic Macular Edema	Phase 2	2007-09-01
Completed	Safety Study of CTS21166 to Treat Alzheimer Disease Alzheimer's Disease	Phase 1	2007-06-01
Terminated	Safety and Efficacy of ATG003 in Patients With Wet Age-Related Macular Degeneration (AMD) Macular Degeneration	Phase 2	2007-03-01
Completed	Safety and Efficacy of GTS21 in Adults With Attention-deficit Hyperactivity Disorder Attention Deficit Hyperactivity Disorder	Phase 1 / Phase 2	2007-02-01
Completed	GTS21-201 for Alzheimer Disease:GTS-21 Administered Daily for 28 Days to Participants With Probable Alzheimer' Alzheimer Disease	Phase 2	2006-11-01
Terminated	Safety and Preliminary Efficacy Study of Nicotine Gel to Treat Diabetic Foot Ulcers Diabetic Foot Ulcers	Phase 1 / Phase 2	2006-10-01